Drawing for TAPROOT

USPTO serial 97526108

TAPROOT

Reviewed by CopyMark Law Group

Reg. 7162099Status 700Registered
Filing date
Status date
Registration date
Sep 12, 2023
Examiner
MURRAY, DAVID T
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TAPROOT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua M. Gerben, Esq.

Joshua M. Gerben, Esq. GERBEN PERROTT, PLLC1050 CONNECTICUT AVE NW, SUITE 500WASHINGTON, DC 20036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research, namely, conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of oncology; Providing a website featuring technology that enables users to upload medical information; Providing temporary use of online, non-downloadable software for uploading medical information; Providing a website featuring technology that enables users to collect, aggregate, access, search, manipulate, store, analyze, share, and research clinical and precision medicine data; Providing temporary use of online, non-downloadable software for collection, aggregation, accessing, searching, manipulation, storage, analysis, sharing, and research clinical and precision medicine data; Providing a website featuring technology that enables users to collect, create, deliver, and share patient diagnostic reports including pathology, radiology, and molecular testing reports; Providing temporary use of online, non-downloadable software for collecting, creating, delivering and sharing patient diagnostic reports including pathology, radiology and molecular testing reports; Providing a website featuring technology that enables users to identify and recruit patients for clinical trials; Providing temporary use of online, non-downloadable software for use in identifying and recruiting patients for clinical trialsACTIVEJul 14, 2022
044Remote monitoring of medical data for medical diagnosis and treatment; Providing information, advice, and data on medical oncologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 12, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 12, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 27, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 27, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 7, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 23, 2023PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 16, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 16, 2023DOCKASSIGNED TO EXAMINER—
Sep 15, 2022AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Sep 15, 2022ALIEASSIGNED TO LIE—
Aug 12, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Aug 2, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance